Top Banner
Long-Term Colorectal-Cancer Incidence and Mortality after Lower Endoscopy Supervisor: 邱邱邱 邱邱 Presented by 邱邱邱 邱邱邱 NEJM, Sep 19, 2013
27

Long-Term Colorectal-Cancer Incidence and Mortality after Lower Endoscopy Supervisor: 邱宗傑 主任 Presented by 郭政裕 總醫師 NEJM, Sep 19, 2013.

Dec 15, 2015

Download

Documents

Amya Pollom
Welcome message from author
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Page 1: Long-Term Colorectal-Cancer Incidence and Mortality after Lower Endoscopy Supervisor: 邱宗傑 主任 Presented by 郭政裕 總醫師 NEJM, Sep 19, 2013.

Long-Term Colorectal-Cancer Incidence and Mortality

after Lower Endoscopy

Supervisor: 邱宗傑 主任Presented by 郭政裕 總醫師

NEJM, Sep 19, 2013

Page 2: Long-Term Colorectal-Cancer Incidence and Mortality after Lower Endoscopy Supervisor: 邱宗傑 主任 Presented by 郭政裕 總醫師 NEJM, Sep 19, 2013.

• Polyp-Cancer sequency ?

Page 3: Long-Term Colorectal-Cancer Incidence and Mortality after Lower Endoscopy Supervisor: 邱宗傑 主任 Presented by 郭政裕 總醫師 NEJM, Sep 19, 2013.
Page 4: Long-Term Colorectal-Cancer Incidence and Mortality after Lower Endoscopy Supervisor: 邱宗傑 主任 Presented by 郭政裕 總醫師 NEJM, Sep 19, 2013.

Morphology, Anatomic Distribution and Cancer Potential of Colonic Polyps. Annals Surgery 1979;190:679-683.

Page 5: Long-Term Colorectal-Cancer Incidence and Mortality after Lower Endoscopy Supervisor: 邱宗傑 主任 Presented by 郭政裕 總醫師 NEJM, Sep 19, 2013.

Morphology, Anatomic Distribution and Cancer Potential of Colonic Polyps. Annals Surgery 1979;190:679-683.

Page 6: Long-Term Colorectal-Cancer Incidence and Mortality after Lower Endoscopy Supervisor: 邱宗傑 主任 Presented by 郭政裕 總醫師 NEJM, Sep 19, 2013.

Familiar adenomatous polyposis (FAP)

• APC mutations (Adenomatous polyposis coli) • An inherited cancer-predisposition syndrome• more than 100 adenomatous polyps • in carriers of the mutant gene, the risk of colorectal cancer by the age of 40 years is almost 100%

Kathleen H. Biology Of The APC Tumor Suppressor. J Clin Oncol 2000;18:1967-1979.

Page 7: Long-Term Colorectal-Cancer Incidence and Mortality after Lower Endoscopy Supervisor: 邱宗傑 主任 Presented by 郭政裕 總醫師 NEJM, Sep 19, 2013.
Page 8: Long-Term Colorectal-Cancer Incidence and Mortality after Lower Endoscopy Supervisor: 邱宗傑 主任 Presented by 郭政裕 總醫師 NEJM, Sep 19, 2013.

• Animal model: • The Apcmin mouse – chemical mutagenesis that introduced a chain-

terminating mutation at nucleotide 2549 in mApc– develop numerous intestinal adenomas in which the

remaining wild-type allele is somatically inactivated during adenoma developmentKathleen H. Biology Of The APC Tumor Suppressor. J Clin Oncol 2000;18:1967-1979.

Page 9: Long-Term Colorectal-Cancer Incidence and Mortality after Lower Endoscopy Supervisor: 邱宗傑 主任 Presented by 郭政裕 總醫師 NEJM, Sep 19, 2013.

Sporadic colorectal adenoma and cancers

• APC – Somatic mutations and

deletions that inactivate both copies of APC are present in most patients

• Wild-type APC– Mutations of β-catenin

resistent to the β-catenin degradation complex Kathleen H. Biology Of The APC Tumor Suppressor. J Clin Oncol 2000;18:1967-1979.

Page 10: Long-Term Colorectal-Cancer Incidence and Mortality after Lower Endoscopy Supervisor: 邱宗傑 主任 Presented by 郭政裕 總醫師 NEJM, Sep 19, 2013.

Sanford D. Moleucular Basis of Colorectal Cancer. N Engl J Med 2009;361:2449-60.

Page 11: Long-Term Colorectal-Cancer Incidence and Mortality after Lower Endoscopy Supervisor: 邱宗傑 主任 Presented by 郭政裕 總醫師 NEJM, Sep 19, 2013.

Sanford D. Moleucular Basis of Colorectal Cancer. N Engl J Med 2009;361:2449-60.

Page 12: Long-Term Colorectal-Cancer Incidence and Mortality after Lower Endoscopy Supervisor: 邱宗傑 主任 Presented by 郭政裕 總醫師 NEJM, Sep 19, 2013.
Page 13: Long-Term Colorectal-Cancer Incidence and Mortality after Lower Endoscopy Supervisor: 邱宗傑 主任 Presented by 郭政裕 總醫師 NEJM, Sep 19, 2013.

Methods

• Study population– Prospective cohort study

• The Nurses’ Health Study: 121,700 U.S. female nurses (30~55 y/o), since 1976

• The Health Professionals Follow-up Study: 51,529 U.S. male health professionals (40~75 y/o), sinc 1986

• Exclusion criteria– History of cancer– Ulcerative colitis– Colorectal polyps– Familiar polyposis syndromes– Previous lower endoscopy

Page 14: Long-Term Colorectal-Cancer Incidence and Mortality after Lower Endoscopy Supervisor: 邱宗傑 主任 Presented by 郭政裕 總醫師 NEJM, Sep 19, 2013.

• Observational studies– Enrolled: n=88,902 (31,736 men, 57,166 women)– 1998~2008– Questionnaire and collect information every 2

year (Low GI endoscopy: sigmoidscopy or colonoscopy)

– Incidence analysis in 2010, mortality analysis in 2012

Page 15: Long-Term Colorectal-Cancer Incidence and Mortality after Lower Endoscopy Supervisor: 邱宗傑 主任 Presented by 郭政裕 總醫師 NEJM, Sep 19, 2013.

• Polyps– Adenomatous polyps – Advanced adenoma (≥10 mm, tubulovillus or

villous, or high-grade dysplasia)– High-risk adenoma ( numbers ≥ 3)– Colonoscopic polypectomy: excision of comfirmed

adenomatous polyps (excluding hyperplastic polyps)

– Negative endoscopy: no adenomas or CRCs

Page 16: Long-Term Colorectal-Cancer Incidence and Mortality after Lower Endoscopy Supervisor: 邱宗傑 主任 Presented by 郭政裕 總醫師 NEJM, Sep 19, 2013.

• Molecular analysis – Microsatellite instability status– BRAF (codon 600)– KRAS (codon 12 and 13)– PIK3CA (exons 9 and 20)– DNA methylation (8 CpG island methylator

phenotype, CIMP)• Specific promotors: MLH1, CACNA1G, CDKN2A, CRABP1,

IGF2, NEUROG1, RUNX3, and SOCS1)• Long interspersed nucleotide element 1 (LINE-1)

Page 17: Long-Term Colorectal-Cancer Incidence and Mortality after Lower Endoscopy Supervisor: 邱宗傑 主任 Presented by 郭政裕 總醫師 NEJM, Sep 19, 2013.
Page 18: Long-Term Colorectal-Cancer Incidence and Mortality after Lower Endoscopy Supervisor: 邱宗傑 主任 Presented by 郭政裕 總醫師 NEJM, Sep 19, 2013.

Results

• 88,902 participants, follow-up for 22 years– Received endoscopy vs. without endoscopy– Colorectal cancer: 1815 incident cases (2%)

Page 19: Long-Term Colorectal-Cancer Incidence and Mortality after Lower Endoscopy Supervisor: 邱宗傑 主任 Presented by 郭政裕 總醫師 NEJM, Sep 19, 2013.
Page 20: Long-Term Colorectal-Cancer Incidence and Mortality after Lower Endoscopy Supervisor: 邱宗傑 主任 Presented by 郭政裕 總醫師 NEJM, Sep 19, 2013.
Page 21: Long-Term Colorectal-Cancer Incidence and Mortality after Lower Endoscopy Supervisor: 邱宗傑 主任 Presented by 郭政裕 總醫師 NEJM, Sep 19, 2013.

Screen colonscopy interval

Page 22: Long-Term Colorectal-Cancer Incidence and Mortality after Lower Endoscopy Supervisor: 邱宗傑 主任 Presented by 郭政裕 總醫師 NEJM, Sep 19, 2013.

Surveillance colonoscopy interval after removal of adenomatous polyps

Page 23: Long-Term Colorectal-Cancer Incidence and Mortality after Lower Endoscopy Supervisor: 邱宗傑 主任 Presented by 郭政裕 總醫師 NEJM, Sep 19, 2013.
Page 24: Long-Term Colorectal-Cancer Incidence and Mortality after Lower Endoscopy Supervisor: 邱宗傑 主任 Presented by 郭政裕 總醫師 NEJM, Sep 19, 2013.
Page 25: Long-Term Colorectal-Cancer Incidence and Mortality after Lower Endoscopy Supervisor: 邱宗傑 主任 Presented by 郭政裕 總醫師 NEJM, Sep 19, 2013.
Page 26: Long-Term Colorectal-Cancer Incidence and Mortality after Lower Endoscopy Supervisor: 邱宗傑 主任 Presented by 郭政裕 總醫師 NEJM, Sep 19, 2013.

Summary

• Low gastrointestinal endoscopy is associated with a low incidence and low mortality of colorectal cancer

• Tumor molecular features of the serrated pathway might be involved in the development of cancer within 5 years after colonoscopy

Page 27: Long-Term Colorectal-Cancer Incidence and Mortality after Lower Endoscopy Supervisor: 邱宗傑 主任 Presented by 郭政裕 總醫師 NEJM, Sep 19, 2013.

Thanks for your attention!